Enable job alerts via email!
Boost your interview chances
Create a job specific, tailored resume for higher success rate.
An established industry player is seeking an Associate Director/Director of Intellectual Property to lead the development of a pioneering Gene Writing vision. This role requires a dynamic individual with a J.D. and significant experience in IP law, particularly within the pharmaceutical and biotechnology sectors. The ideal candidate will thrive in a fast-paced environment, collaborating with scientists and corporate teams to manage and expand the company's IP portfolio. This is a unique opportunity to be at the forefront of genetic medicine, contributing to groundbreaking advancements that could redefine treatment paradigms. If you have a passion for innovation and a strategic mindset, this role is perfect for you.
Join to apply for the Associate Director/Director, Intellectual Property (Patent Counsel) role at Tessera Therapeutics.
You are an experienced Patent Counsel who thrives working in a fast-paced, highly interactive environment with a broad range of intellectual property matters helping to build and maintain a strong IP portfolio, protecting a broad range of internal and in-licensed innovation and technology. You are excited about working closely with Scientists, Corporate Development, management, and outside counsel. You have excellent command of U.S. and international intellectual property laws and expertise in building complex patent estates for genetic medicines platforms and products. You are a driven, enthusiastic and self-motivated individual who is comfortable multitasking and working independently on various aspects of the platform. You are interested in joining a dynamic, rapidly growing, and highly collaborative team.
All inquiries regarding the posted position should be directed to the Talent Partner (see below). Interested individuals must apply directly to be considered for the opening.
Ian Lodovice - Vice President, Head of Intellectual Property
Tessera Therapeutics is pioneering Gene Writing— a new biotechnology designed to offer scientists and clinicians the ability to write small and large therapeutic messages into the genome, thereby curing diseases at their source. Gene Writing holds the potential to become a new category in genetic medicine, building upon recent breakthroughs in gene therapy and gene editing while eliminating important limitations in their reach, utilization, and efficacy. Tessera Therapeutics was founded by Flagship Pioneering, a life sciences innovation enterprise that conceives, resources, and develops first-in-category companies to transform human health and sustainability.
Tessera is proud to be an Equal Opportunity Employer. All qualified applicants will receive consideration for employment without regard to race, color, religion, age, sex, national origin, disability status, marital status, genetics, protected veteran status, citizenship status, sexual orientation, gender identity or expression, or any other characteristic identified by federal, state, or local laws where we operate.